Lanx Inc. Announces Corporate Expansion

Company Adds to Executive Team and Expands Corporate Facility

        Print
| Source: Biomet Spine

BROOMFIELD, Colo., Jan. 10, 2012 (GLOBE NEWSWIRE) -- Lanx Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, today announced that it has expanded its executive team in Operations, International, Clinical & Regulatory Affairs, Marketing, Research & Development, and Legal. In addition, Lanx has expanded its corporate facility, and combined its operations into a single 80,000 square foot facility.

Dan Gladney, Chairman and Chief Executive Officer, Lanx, commented, "As Lanx continues to expand its global market share, we have added key executives to our team with significant spine experience and track records of success. Additionally, our expanded corporate facility positions Lanx to offer enhanced service to our customers as we further develop innovative and less invasive treatment options and increase the scale of our business."

Wayne Chrystal joins Lanx as Vice President of Operations with more than 20 years of operations experience in various multinational entities. Prior to Lanx, Chrystal was the Vice President of Operations at Compex Technologies, a then publicly traded international medical device company.

Michael Hughes has been appointed Senior Vice President of International to lead the company's ongoing international business expansion. He has nearly two decades of sales and sales management experience in the medical device and spine industry, including over 14 years with Biomet, Inc. & Interpore Cross, where he was responsible for their international spine expansion.

Pamela Snyder joins Lanx as Senior Vice President of Clinical & Regulatory Affairs. Snyder brings more than 25 years of experience in the spine and medical device industries, specializing in clinical and regulatory affairs, strategic development, program implementation and management and clinical research. Before coming to Lanx, Snyder served as Principle Regulatory and Clinical Consultant for US and OUS medical device companies, in addition to serving as the Director of Clinical & Regulatory Affairs at Spineology, Inc.

Paul Hickey has been appointed Senior Vice President of Marketing and Research & Development. He brings over 20 years of spine and medical device experience in global strategic planning, marketing, new business development, and product development. Hickey was at Zimmer, Inc. for 18 years, including several key orthopedic and spine marketing and engineering leadership roles, most recently serving as Vice President of Global R&D and Emerging Technology for Zimmer Spine.

Dana Klapper Cohen has joined Lanx as General Counsel. Cohen brings almost two decades of legal experience to Lanx's management team. Before joining Lanx, Cohen served as the General Counsel for Bacterin International, Inc., a publicly traded biotechnology company. In this role she was responsible for all of the company's legal matters and served as the sole in-house legal resource for the company's initial public stock offering.

The new Lanx campus in Broomfield, CO, now totals 80,000 square feet, offering expanded surgeon training and accredited device testing facilities and an upgraded device prototype lab. It also includes a new, larger product showcase to feature the Company's growing platform of spinal stabilization and fusion technologies, including its flagship Aspen™ MIS Fusion System.

For more information about Lanx, please visit www.lanx.com.

About Lanx Inc.

Lanx is one of the largest privately held global spine companies. The Company was founded by a team of experienced medical device professionals and engineers in 2003 to improve the quality of spine care and provide surgeons with innovative products. Lanx develops and markets a full line of fusion technologies with a focus on minimally invasive and biologics products. The Company is headquartered in Broomfield, CO. More information on Lanx and its spinal surgery products can be found at www.lanx.com.

Steve Deitsch
Chief Financial Officer
(303) 443-7500


Media / Investors:
Kim Muscara / Nick Laudico
(646) 536-7011 / 7030